Early Bird Abstracts Submission closes on 13th May 2025
International Conference on

Hematology and Blood Disorders

October 20-21, 2025
City Seasons Suites, Dubai, UAE
Home > Call For Paper > Novel Anticoagulants and Antiplatelet Agents

Novel Anticoagulants and Antiplatelet Agents

Novel anticoagulants and antiplatelet agents are a class of drugs designed to prevent blood clot formation in patients at risk of thrombotic events, such as stroke, heart attack, or deep vein thrombosis (DVT). These drugs work by targeting specific pathways in the coagulation cascade or platelet activation process to reduce clotting. Unlike traditional anticoagulants (like warfarin) and antiplatelet drugs (like aspirin), novel agents tend to offer benefits like more predictable effects, fewer drug interactions, and easier dosing schedules.

Key Topics:

  • Direct Oral Anticoagulants (DOACs)
  • Targeted Antiplatelet Therapy
  • Anticoagulants and Platelet Inhibition in Cardiovascular Disease
  • Novel Oral Anticoagulants (NOACs) in Special Populations
  • Reversal Agents for Novel Anticoagulants
  • Novel Anticoagulants in Cancer
  • Clinical Trial Design and Outcome Measures in Anticoagulation Therapy
  •  Safety and Efficacy in Real-World Populations
  • Long-Term Safety Data
  • Reversal Agents for New Anticoagulants
  • Combination Therapies
  • Personalized Medicine and Targeted Therapy
  • Novel Anticoagulants in Cancer Treatment
  • The Role of NOACs in Atrial Fibrillation
  • Impact on Bleeding Risk and Management
  • Cost-Effectiveness of Novel Anticoagulants
  • Biosimilars for Novel Anticoagulants

Related Tags: Blood Disorders Conference | Hematologic Research Symposium | Red and White Blood Cells Congress | Platelet Disorders Meeting | Hematopoiesis Symposium | Blood Physiology Congress | Clinical Hematology Conference | Diagnostic Hematology Meeting | Genetic Hematology Disorders Symposium | Hematopathology Congress | Rare Blood Disorders Gathering | Hematologic Biomarkers Symposium | Advanced Treatment Modalities Congress | Hematologic Disease Management Meeting | Blood Disorders in Pediatrics Symposium | Hematology Conference | Hematology Congress | Hematology Summit | Hematology Meeting | International Hematology Conference | Global Hematology Congress | Annual Hematology Summit | World Hematology Meeting | Advances in Hematology Conference | Innovations in Hematology Congress | Hematology and Blood Disorders Summit | Modern Hematology Meeting | Clinical Hematology Congress | Hematology Research Conference | Frontiers in Hematology Summit | Hematology Experts Meeting | NextGen Hematology Congress

Related Societies: Society of Cardiovascular Patient Care | Thrombosis Canada |
Argentine Society of Hematology (SAH) | Hellenic Society of Haematology (HSH) | Polish Society of Haematology and Transfusion Medicine (PTHiT) | Norwegian Society of Hematology | Swedish Society of Hematology (SSH) | Czech Hematology Society | Slovak Society of Hematology and Transfusion Medicine | Israeli Society of Hematology and Transfusion Medicine (ISHTM) | Saudi Society of Hematology (SSH) | Emirates Society of Haematology (ESH) | Emirates Medical Association (EMA) | Emirates Oncology Society (EOS) | Emirates Oncology and Hematology Nursing Society (EOHNS) | Gulf Cooperation Council (GCC)  | Society for Blood Transfusion | Dubai Oncology Center (DOC) | UAE National Cancer Consortium | Dubai College of Medical Sciences | Arab Association for Hematology (AAH) | Middle East Society of Oncology (MESO)

 

SUBMIT ABSTRACT
  +1-404-759-8307
Subscribe To Our Newsletter
094589
TOP